Genomind 360
Learning Center

Healthcare providers

Continuing Medical Education: When, Why, and How to Integrate Pharmacogenetic Testing into Clinical Practice

When, Why, and How to Integrate Pharmacogenetic Testing into Clinical Practice

Genomind has partnered with the Neuroscience Education Institute (NEI) to provide clinicians with a free continuing medical education (CME) opportunity. Learn about the “When, Why, and How to Integrate Pharmacogenetic Testing into Clinical Practice” with Dr. Stephen M. Stahl, MD, PhD. This CME activity is accredited by ACCME for 1.25 hours of AMA PRA Category 1 CME credits and by ACPE for continuing pharmacy education.

Objectives of the course are to:

  • Explain genetic polymorphisms associated with mental health disorders and treatment responses
  • Identify patients for whom pharmacogenetic testing could be an appropriate part of the overall treatment plan
  • Interpret pharmacogenetic test results and communicate the findings to patients and families

Please note that this course is available for free to all registered participants. You will be prompted to log in or create an account through NEI to confirm your eligibility to redeem the credit and track completed courses.

 

Are You Ready to Upgrade Your Practice with Genomind?

Get smarter mental health prescribing guidance that’s good for life. Genomind® Professional PGx Express™ is the most advanced and comprehensive mental health pharmacogenetic test available. Get access to 24 genes related to mental health, 130+ medications, 10+ conditions, state-of-the-art tools, and 360 degrees of support today! 

 

Continued education to evolve your practice.

Free educational content and resources direct from the Genomind team.

This field is for validation purposes and should be left unchanged.